Armenian Medical NetworkHealth.am
Health centers
CancerHeart & Blood VesselsBrain & NervesMental HealthDiabetes & HormonesWeight & NutritionWomen's HealthPregnancy & FertilityChildren's HealthSexual HealthMen's HealthInfections, HIV & STIsLungs, Asthma & AllergiesDigestive HealthBones, Joints & PainSkin, Hair & BeautyEyes, Ears & TeethAddictionSleepHealthy AgingPublic HealthMedicines & Treatments

References

References


  1. Trussel J, Vaughan B: Contraceptive use projections: 1990 - 2010. Am J Obstet Gynecol 1992; 167:1160 - 1164.
  2. US Bureau of the Census: Fertility of American women. June 1988. Curr Pop Reprod 1989;436: 20 - 24.
  3. Creatsas G, Vekemans M, Horejsi J, et al: Adolescent sexuality in Europe: A multicentric study. Adolesc Pediatr Gynecol 1995;8:59 - 63.
  4. Everett SA, Warren CV, Santelli JS, Kann C, Collins JL, Kolbe LJ: Use of birth control pills, condoms and withdrawal among high school students. J Adolesc Health 2000;27:112 - 118.
  5. Speroff L, Darney P: A Clinical Guide for Contraception. Philadelphia, Williams & Wilkins, 1996, p 5.
  6. Weisberg E, North P, Buxton M: Sexual activity and condom use in high school students. Med J Aust 1992;156:612 - 613.
  7. Creatsas G, Hassan E: Education and adolescent sexual behavior in contraceptive choices and reality; in van Lunsen RHW, Unzeiting V, Creatsas G (eds): Proceedings 5th Congress of the European Society of Contraception. London, Parthenon, 1998, pp 44 - 50.
  8. Creatsas E, Koliopoulos C, Mastorakos G: Combined oral contraceptives treatment of adolescent girls with polycystic ovary syndrome. Ann NY Acad Sci 2000;900:245 - 252.
  9. Oosterbaan HP: An open-label study of the effects of a 24-day regimen of gestodene 60µg ethinylestradiol 15µ g on endometrial histological finding in healthy women. Eur J Contracept Reprod Health Care 1999;4(suppl 2):3 - 8.
  10. Creatsas G, Adamopoulos P, Eleftheriou N: Clinical and metabolic effects of the monophasic gestodene ethinylestradiol pill for contraception during adolescence. Adolesc Pediatr Gynecol 1991;4:76 - 79.
  11. Cromer BA: Depo-Provera®: Wherefore art thou? Adolesc Pediatr Gynecol 1992;5:155 - 162.
  12. Cardamakis E, Creatsas G, Deligeoroglou E, Tzingounis V: Norplant subdermal implant system as long-term contraception during adolescence (unpubl data).
  13. Psychoyos A, Creatsas G, Hassan E, Georgoulias V, Gravanis E: Spermicidal and antiviral properties of cholic acid. Contraceptive efficacy of a new vaginal sponge (Protectaid®) containing sodium cholate. Hum Reprod 1993;8:866 - 869.
  14. Creatsas G, Guerrero E, Guilbert E, Drouin J, Serfaty D, Lemieux L, Suissa S, Colin P: A multinational evaluation of the efficacy, safety and acceptability of the Protectaid contraceptive sponge. Eur J Contracept Reprod Health Care 2001;6:172 - 182.
  15. Shihata AA: The FemCap®: A new contraceptive choice; in van Lunsen RHW, Unzeiting V, Creatsas G (eds): Contraceptive Choices and Realities. Proceedings 5th Congress of the European Society of Contraception. London, Parthenon, 1998, pp 173 - 180.
  16. Alan Guttmacher Institute: Teenage Pregnancy: The Problem That Hasn’t Gone Away. New York, Alan Guttmacher Institute, 1981.
  17. Van Lunsen RHW, Arnolds HT, van Maris MGM: Choices and changes in contraceptive behavior: The role of information sources. Patient Educ Couns 1994;23:197 - 202.
  18. Creatsas G: Improving adolescent sexual behavior: A tool for better fertility outcome and safe motherhood. Int J Gynecol Obstet 1997;58:85 - 92.
  19. Fergusson D, Lynskey M: Alcohol misuse, adolescent sexual behaviors and risk taking. Pediatrics 1996;98:91 - 96.
  20. UNDP/UNFPA/WHO/World Bank: Special programme of research development and research. Training in human reproduction (HRP). Biennial report 1994 - 95. Geneva, WHO, 1996.
  21. Diczfalusy E: The demographic revolution and our common future. Maturitas 2001;38:5 - 14.